FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Günther Konwalinka

Research Profile

Chemicals & Drugs

Anatomy

Procedures

Colony Forming Units Assays

Physiology

Concepts & Ideas

Drug Dose Response Relationship

Co-author Network

Publications

TOP 3
Katharina Kurz; Yordanka Gluhcheva; Elissaveta Zvetkova; Günther Konwalinka; Dietmar Fuchs
Interferon-gamma-mediated pathways are induced in human CD34(+) haematopoietic stem cells.
Gerald Gollmann; Hannes Neuwirt; Christoph H Tripp; Hansgeorg Mueller; Günther Konwalinka; Christine Heufler; Nikolaus Romani; Martin Tiefenthaler
Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions.
Hannes Neuwirt; Hansgeorg Muller; Ilaria T R Cavarretta; Martin Tiefenthaler; Georg Bartsch; Günther Konwalinka; Zoran Culig
Akacid-medical-formulation, a novel biocidal oligoguanidine with antitumor activity reduces S-phase in prostate cancer cell lines through the Erk 1/2 mitogen-activated protein kinase pathway.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Günther Konwalinka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Katharina Kurz; Yordanka Gluhcheva; Elissaveta Zvetkova; Günther Konwalinka; Dietmar Fuchs
Interferon-gamma-mediated pathways are induced in human CD34(+) haematopoietic stem cells.
Immunobiology 2010;215(6):452-7.
2008: Gerald Gollmann; Hannes Neuwirt; Christoph H Tripp; Hansgeorg Mueller; Günther Konwalinka; Christine Heufler; Nikolaus Romani; Martin Tiefenthaler
Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions.
International immunology 2008;20(7):911-23.
2006: Hannes Neuwirt; Hansgeorg Muller; Ilaria T R Cavarretta; Martin Tiefenthaler; Georg Bartsch; Günther Konwalinka; Zoran Culig
Akacid-medical-formulation, a novel biocidal oligoguanidine with antitumor activity reduces S-phase in prostate cancer cell lines through the Erk 1/2 mitogen-activated protein kinase pathway.
International journal of oncology 2006;29(2):503-12.
2006: Nicole Bacher; Martin Tiefenthaler; Sonja Sturm; Hermann Stuppner; Michael J Ausserlechner; Reinhard Kofler; Günther Konwalinka
Oxindole alkaloids from Uncaria tomentosa induce apoptosis in proliferating, G0/G1-arrested and bcl-2-expressing acute lymphoblastic leukaemia cells.
British journal of haematology 2006;132(5):615-22.
2005: Ralf Herwig; Wolfgang Horninger; Peter Rehder; Helmut Klocker; Reinhold Ramoner; Martin Thurnher; Germar-M. Pinggera; Christian Gozzi; Günther Konwalinka; Georg Bartsch
Ability of PSA-positive circulating macrophages to detect prostate cancer.
The Prostate 2005;62(3):290-8.
2005: Hansgeorg Müller; Susanne Hofer; Nicole Kaneider; Hannes Neuwirt; Birgit A Mosheimer; Gert Mayer; Günther Konwalinka; Christine Heufler; Martin Tiefenthaler
The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells.
European journal of immunology 2005;35(2):533-45.
2004: Ralf Herwig; Alexandre Pelzer; Wolfgang Horninger; Peter Rehder; Helmut Klocker; Reinhold Ramoner; Germar-M. Pinggera; Christian Gozzi; Günther Konwalinka; Georg Bartsch
Measurement of intracellular versus extracellular prostate-specific antigen levels in peripheral macrophages: a new approach to noninvasive diagnosis of prostate cancer.
Clinical prostate cancer 2004;3(3):184-8.
2004: Seonghyang Sohn; Manfred Lutz; Hyuk Jae Kwon; Günther Konwalinka; Sungnack Lee; Michael Schirmer
Therapeutic effects of gemcitabine on cutaneous manifestations in an Adamantiades-Behçet's disease-like mouse model.
Experimental dermatology 2004;13(10):630-4.
2004: Michael Steurer; Gernot Fritsche; Alexandar Tzankov; Thaddaeus Gotwald; Wolfgang Sturm; Günther Konwalinka; J Gruber
Large-vessel arteritis and myelodysplastic syndrome: report of two cases.
European journal of haematology 2004;73(2):128-33.
2004: Günter Weiss; Katharina Schroecksnadel; Verena Mattle; Christiane Winkler; Günther Konwalinka; Dietmar Fuchs
Possible role of cytokine-induced tryptophan degradation in anaemia of inflammation.
European journal of haematology 2004;72(2):130-4.
2003: Kathrin Renner; Albert Amberger; Günther Konwalinka; Reinhard Kofler; Erich Gnaiger
Changes of mitochondrial respiration, mitochondrial content and cell size after induction of apoptosis in leukemia cells.
Biochimica et biophysica acta 2003;1642(1-2):115-23.
2003: Martin Tiefenthaler; Nicole Bacher; H Linert; Oliver Mühlmann; Susanne Hofer; Norbert Sepp; Albert Amberger; FH Geisen; Gerlinde Obermoser; Günther Konwalinka
Apoptosis of CD34+ cells after incubation with sera of leukopenic patients with systemic lupus erythematosus.
Lupus 2003;12(6):471-8.
2003: Martin Tiefenthaler; Florian Hohla; Elisabeth Strasser-Wozak; Nicole Bacher; Oliver Mühlmann; Wolfgang Wein; Günther Konwalinka
Delayed addition of deoxycytidine protects normal CD34+ cells against cytotoxicity of gemcitabine without compromising its activity against human leukemic cells.
Stem cells (Dayton, Ohio) 2003;21(3):266-71.
2003: Martin Tiefenthaler; Florian Hohla; Eveline U Irschick; Elisabeth Strasser-Wozak; Nicole Bacher; Oliver Mühlmann; Wolfgang Wein; Günther Konwalinka
In vitro studies on the immunosuppressive effect of 2',2'-difluorodeoxycytidine (dFdC) and its metabolite 2',2'-difluorodeoxyuridine (dFdU).
Immunobiology 2003;207(2):149-57.
2001: Martin Tiefenthaler; Albert Amberger; Nicole Bacher; BL Hartmann; Raimund Margreiter; Reinhard Kofler; Günther Konwalinka
Increased lactate production follows loss of mitochondrial membrane potential during apoptosis of human leukaemia cells.
British journal of haematology 2001;114(3):574-80.
2000: Hannes Strasser; Martin Tiefenthaler; Martin Steinlechner; Iris E Eder; Georg Bartsch; Günther Konwalinka
Age dependent apoptosis and loss of rhabdosphincter cells.
The Journal of urology 2000;164(5):1781-5.
2000: Michael Schirmer; Margot Haun; Kurt Grünewald; FH Geisen; Wolfgang Hilbe; Josef Thaler; Günther Konwalinka
New rearrangement pattern after treatment of hairy-cell leukemia with 2-chlorodeoxyadenosine.
Acta haematologica 2000;103(2):109-11.
1999: Michael Schirmer; FH Geisen; Martin Tiefenthaler; Günther Konwalinka
Differential effects of cladribine and gemcitabine on erythroid and granulocytic progenitors from patients with chronic myeloid leukemia.
Leukemia research 1999;23(12):1121-6.
1999: Raimund Margreiter; M Fischer; Kurt Roberts; T Schmid; Anton Hittmair; Michael Schirmer; FH Geisen; Martin Tiefenthaler; Günther Konwalinka
Gemcitabine--a novel immunosuppressive agent--prevents rejection in a rat cardiac transplantation model.
Transplantation 1999;68(7):1051-3.
1999: Hannes Strasser; Martin Tiefenthaler; Martin Steinlechner; G Bartsch; Günther Konwalinka
Urinary incontinence in the elderly and age-dependent apoptosis of rhabdosphincter cells.
Lancet 1999;354(9182):918-9.
1999: Christian Zidorn; Hermann Stuppner; Martin Tiefenthaler; Günther Konwalinka
Cytotoxic activities of hypocretenolides from Leontodon hispidus.
Journal of natural products 1999;62(7):984-7.
1999: Wolfgang Hilbe; T Berger; Günther Konwalinka; Josef Thaler
Cladribine treatment of a patient with hairy cell leukemia and concomitant multiple sclerosis.
Acta haematologica 1999;102(2):99-100.
1998: Michael Schirmer; A P Stegmann; FH Geisen; Günther Konwalinka
Lack of cross-resistance with gemcitabine and cytarabine in cladribine-resistant HL60 cells with elevated 5'-nucleotidase activity.
Experimental hematology 1998;26(13):1223-8.
1998: Zoran Culig; Alfred Hobisch; M Herold; Anton Hittmair; Martin Thurnher; Iris E Eder; MV Cronauer; C Rieser; Reinhold Ramoner; Georg Bartsch; Helmut Klocker; Günther Konwalinka
Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells.
British journal of cancer 1998;78(8):1004-11.
1998: Wolfgang Hilbe; Ute Apfelbeck; Michael Fridrik; M Bernhart; H Niessner; K Abbrederis; G Michlmayr; Jörg Pont; Werner Linkesch; Hubert Hausmaninger; K Arneitz; Christian Baldinger; C Duba; Wolfgang Eisterer; richard greil; Günther Konwalinka; Dietger Niederwieser; Guenther Gastl; Josef Thaler
Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemia.
Leukemia research 1998;22(10):881-6.
1998: Ivo W Graziadei; T Kelly; Michael Schirmer; FH Geisen; Wolfgang Vogel; Günther Konwalinka
Antitumor effect of the nucleoside analogs 2-chlorodeoxyadenosine and 2',2'-difluorodeoxycytidine on human hepatoma HepG2 cells.
Journal of hepatology 1998;28(3):504-9.
1998: T Schmid; Paul Hechenleitner; Walter Mark; M Fischer; Kurt Roberts; FH Geisen; Günther Klima; Otto Dietze; Günther Konwalinka; Raimund Margreiter
2-Chlorodeoxyadenosine (cladribine) in combination with low-dose cyclosporin prevents rejection after allogeneic heart and liver transplantation in the rat.
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 1998;30(1):61-8.
1997: Martin Tiefenthaler; FH Geisen; Michael Schirmer; Günther Konwalinka
A comparison of the antiproliferative properties of recombinant human IFN-alpha 2 and IFN-omega in human bone marrow culture.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1997;17(6):327-9.
1997: Bettina G Zelger; Bernhard W H Zelger; Günther Konwalinka; Gregor Mikuz; Falko Fend
Non-Hodgkin lymphoma with exclusive involvement of the heart and the gastrointestinal tract.
Virchows Archiv : an international journal of pathology 1997;430(5):427-30.
1997: Michael Schirmer; Erich Mur; Karl P Pfeiffer; Josef Thaler; Günther Konwalinka
The safety profile of low-dose cladribine in refractory rheumatoid arthritis. A pilot trial.
Scandinavian journal of rheumatology 1997;26(5):376-9.
1997: Michael Schirmer; Wolfgang Hilbe; FH Geisen; Josef Thaler; Günther Konwalinka
T cells and natural killer cells after treatment of hairy cell leukaemia with 2-chlorodeoxyadenosine.
Acta haematologica 1997;97(3):180-3.
1997: Josef Thaler; Wolfgang Hilbe; Ute Apfelbeck; Werner Linkesch; Heinz Sill; HL Seewann; Jörg Pont; M Bernhart; M Stöger; H Niessner; K Abbrederis; D Geissler; Hubert Hausmaninger; W Lin; Heinz Ludwig; A Lang; C Duba; T Fluckinger; richard greil; Kurt Grünewald; Günther Konwalinka; Dietger Niederwieser; Michael Fridrik
Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.
Leukemia research 1997;21(1):75-80.
1996: Iradj Mohsenipour; Michael Schirmer; R Frank; FH Geisen; E Semenitz; D zur Nedden; Günther Konwalinka
Local application of antimycotics in mucormycosis cerebri: a case report.
Journal of neurology, neurosurgery, and psychiatry 1996;61(5):521-2.
1996: Michael Schirmer; G Michlmayr; FH Geisen; Günther Konwalinka
2-Chlorodeoxyadenosine (2-CdA) in chronic lymphocytic leukemia refractory to fludarabine?
Leukemia 1996;10(7):1253-4.
1996: J Gruber; FH Geisen; Roswitha Sgonc; Alexander Egle; Andreas Villunger; G Boeck; Günther Konwalinka; richard greil
2',2'-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA).
Stem cells (Dayton, Ohio) 1996;14(3):351-62.
1996: MV Cronauer; Helmut Klocker; Heribert Talasz; FH Geisen; Alfred Hobisch; Christian Radmayr; G Böck; Zoran Culig; Michael Schirmer; A Reissigl; Georg Bartsch; Günther Konwalinka
Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cells.
The Prostate 1996;28(3):172-81.
1995: A L Petzer; FH Geisen; R Bilgeri; U Zilian; Margot Haun; M Herold; H Braunsteiner; Günther Konwalinka
Growth-inhibitory effect of 2-CdA on myeloid CFU-GM progenitors in normal human long-term bone marrow cultures and its compensation by G-CSF or IL-3.
Experimental hematology 1995;23(6):529-34.
1995: Günther Konwalinka; Michael Schirmer; Wolfgang Hilbe; Falko Fend; FH Geisen; A Knoblechner; A Petzer; Josef Thaler
Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
Blood cells, molecules & diseases 1995;21(2):142-51.
1995: August Zabernigg; Wolfgang Hilbe; Norbert Reinisch; Wolfgang Eisterer; Josef Thaler; L Spötl; Günther Konwalinka
Normal granulocyte function but impaired monocyte function in a patient with aplastic anemia.
Acta haematologica 1995;94(2):109-11.
1994: G Oberhuber; T Schmid; W Thaler; A Kaltenbacher; Michael Schirmer; J Liliemark; P Herbst; FH Geisen; Raimund Margreiter; Günther Konwalinka
Evidence that 2-chlorodeoxyadenosine in combination with cyclosporine prevents rejection after allogeneic small bowel transplantation.
Transplantation 1994;58(6):743-5.
1994: Monika Lechleitner; Bernhard Auer; U Zilian; Friedrich Hoppichler; Michael Schirmer; Bernhard Föger; FH Geisen; Josef R Patsch; Günther Konwalinka
The immunosuppressive substance 2-chloro-2-deoxyadenosine modulates lipoprotein metabolism in a murine macrophage cell line (P388 cells).
Lipids 1994;29(9):627-33.
1994: Michael Schirmer; Wolfgang Vogel; Josef Thaler; Kurt Grünewald; F Umlauft; FH Geisen; U Zilian; Günther Konwalinka
Fulminant hepatitis C virus infection.
Lancet 1994;343(8910):1433.
1994: T Schmid; G Oberhuber; W Thaler; A Kaltenbacher; P Herbst; Raimund Margreiter; Günther Konwalinka
2-Chlorodeoxyadenosine in combination with cyclosporine prevents rejection after allogeneic small bowel transplantation.
Transplantation proceedings 1994;26(3):1614.
1993: R Bilgeri; A L Petzer; U Zilian; FH Geisen; Michael Schirmer; Margot Haun; Günther Konwalinka
Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
Experimental hematology 1993;21(3):432-7.
1993: Tessa L Holyoake; M G Freshney; Günther Konwalinka; Margot Haun; A Petzer; E Fitzsimons; N P Lucie; Eric G Wright; I B Pragnell
Mixed colony formation in vitro by the heterogeneous compartment of multipotential progenitors in human bone marrow.
Leukemia 1993;7(2):207-13.
1992: Monika Lechleitner; Friedrich Hoppichler; Günther Konwalinka; Josef R Patsch; H Braunsteiner
Depressive symptoms in hypercholesterolaemic patients treated with pravastatin.
Lancet 1992;340(8824):910.
1991: A L Petzer; R Bilgeri; U Zilian; Margot Haun; FH Geisen; I Pragnell; H Braunsteiner; Günther Konwalinka
Inhibitory effect of 2-chlorodeoxyadenosine on granulocytic, erythroid, and T-lymphocytic colony growth.
Blood 1991;78(10):2583-7.
1991: Kurt Grünewald; Norbert Sepp; K Weyrer; Karl Lhotta; H Feichtinger; Günther Konwalinka; S M Breathnach; Helmut Hintner
Gene rearrangement studies in the diagnosis of primary systemic and nodular primary localized cutaneous amyloidosis.
The Journal of investigative dermatology 1991;97(4):693-6.
1990: D Geissler; Guenther Gastl; Walter Aulitzky; Herbert Tilg; S Gaggl; Günther Konwalinka; Christoph Huber
Recombinant interferon-alpha-2C in chronic myelogenous leukaemia: relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical response.
Leukemia research 1990;14(7):629-36.
1989: D Geissler; Heinz Zwierzina; Christoph Pechlaner; S Gaggl; F Schmalzl; Günther Konwalinka; H Braunsteiner
Abnormal megakaryopoiesis in patients with myelodysplastic syndromes: analysis of cellular and humoral defects.
British journal of haematology 1989;73(1):29-35.
1989: Christian Wiedermann; R Bilgeri; A Petzer; C Gattringer; D Geissler; Günther Konwalinka
Multipotent stem cell origin of myelodysplastic syndromes.
Blood 1989;73(8):2230.
1988: D Geissler; Dietger Niederwieser; Walter Aulitzky; H Tilg; Kurt Grünewald; Christoph Huber; Günther Konwalinka
Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
Behring Institute Mitteilungen 1988;(83):289-300.
1988: Günther Konwalinka; C Breier; D Geissler; C Peschel; Christian Wiedermann; Josef R Patsch; H Braunsteiner
Proliferation and differentiation of human erythropoiesis in vitro: effect of different human lipoprotein species.
Experimental hematology 1988;16(2):125-30.
1988: Günther Konwalinka; Christian Wiedermann; A Petzer; K Grunewald; C Breier; Josef R Patsch; D Geissler
Stimulation of human early and late erythropoietic progenitor cells by insulin: evidence for different mechanisms.
Advances in experimental medicine and biology 1988;241():273-80.
1986: Günther Konwalinka; D Geissler; C Peschel; C Breier; Kurt Grünewald; R Odavic; H Braunsteiner
Human erythropoiesis in vitro and the source of burst-promoting activity in a serum-free system.
Experimental hematology 1986;14(10):899-903.
1986: Günther Konwalinka; C Breier; C Peschel; D Geissler; H J Lisch; H Braunsteiner
Effect of human plasmalipoproteins on erythropoietic progenitor cells in serum-free cultures.
Blut 1986;52(3):191-5.
1985: Günther Konwalinka; C Peschel; F Schmalzl; H E Schaefer; D Geissler; G Schuler; H Huber; B Tomaschek; R Odavic; H Braunsteiner
CFU-gm assay, cytochemical and electron microscopic studies in agar in patients with preleukemic syndrome and aplastic anemia.
International journal of cell cloning 1985;3(6):367-87.
1985: D Geissler; Günther Konwalinka; C Peschel; Kurt Grünewald; R Odavic; H Braunsteiner
A regulatory role of activated T-lymphocytes on human megakaryocytopoiesis in vitro.
British journal of haematology 1985;60(2):233-8.
1984: Günther Konwalinka; C Peschel; J Boyd; D Geissler; M Ogriseg; R Odavic; H Braunsteiner
A miniaturized agar culture system for cloning human erythropoietic progenitor cells.
Experimental hematology 1984;12(1):75-9.
1983: Günther Konwalinka; C Peschel; D Geissler; J Boyd; B Tomaschek; R Odavic; H Braunsteiner
Myelopoiesis of human bone marrow cells in a micro-agar culture system: comparison of two sources of colony stimulating activity (CSA).
International journal of cell cloning 1983;1(5):401-11.
1983: D Geissler; Günther Konwalinka; C Peschel; J Boyd; R Odavic; H Braunsteiner
Clonal growth of human megakaryocytic progenitor cells in a micro-agar culture system: simultaneous proliferation of megakaryocytic, granulocytic, and erythroid progenitor cells (CFU-M, CFU-C, BFU-E) and T-lymphocytic colonies (CFU-TL).
International journal of cell cloning 1983;1(5):377-88.
1983: C Peschel; Günther Konwalinka; D Geissler; B Tomaschek; Kurt Grünewald; H Huber; R Odavic; H Braunsteiner
Studies of myelopoiesis in vitro on blood and bone marrow cells of patients with acute leukemia in long-term remission.
Leukemia research 1983;7(3):397-406.
1983: Günther Konwalinka; C Huber; B Tomaschek; C Peschel; D Geissler; R Odavic; H Braunsteiner
A case of acquired pure red cell anemia studied by cloning of erythroid progenitor cells in vitro.
Acta haematologica 1983;70(5):316-24.
1982: Günther Konwalinka; D Geissler; C Peschel; B Tomaschek; R Odavic; H Braunsteiner
[Proliferation of myeloid precursor cells in a microagar culture system].
Acta medica Austriaca 1982;9(3):109-10.
1982: Günther Konwalinka; D Geissler; C Peschel; B Tomaschek; F Schmalzl; H Huber; R Odavic; H Braunsteiner
A micro agar culture system for cloning human erythropoietic progenitors in vitro.
Experimental hematology 1982;10(1):71-7.
1982: Günther Konwalinka; C Peschel; D Geissler; B Tomaschek; C Gattringer; R Odavic; H Braunsteiner
[A microagar culture system for clonal growth of human T-lymphocytes].
Acta medica Austriaca 1982;9(3):99-102.
1982: Günther Konwalinka; C Peschel; D Geissler; B Tomaschek; G Schuler; F Schmalzl; H Schaefer; H Huber; R Odavic; H Braunsteiner
[Bone marrow culture, cytochemistry and electron microscopy in agar in patients with preleukemic syndrome and aplastic anemia].
Acta medica Austriaca 1982;9(3):103-8.
1980: Günther Konwalinka; P Glaser; R Odavic; E Bogusch; F Schmalzl; H Braunsteiner
A new approach to the morphological and cytochemical evaluation of human bone marrow CFUC in agar cultures.
Experimental hematology 1980;8(4):434-40.